Skip to main content
. 2020 May 10;99(7):1505–1514. doi: 10.1007/s00277-020-04052-z

Fig. 1.

Fig. 1

Proportion of patients with HDA stratified by percentage of GPI-deficient granulocytes at baseline aPatients with available data. GPI glycosylphosphatidylinositol; HDA high disease activity